抑制剂溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 产品编号 | 图片 | 产品描述 | 分子式 | 加入购物车 | |
|---|---|---|---|---|---|
|
CFMTI，98% | C19H16FN5O | |||
|
|
|||||
|
Umeclidinium Bromide，99% | C29H34BrNO2 | |||
|
|
|||||
|
E 2012，96% | C25H26FN3O2 | |||
|
|
|||||
|
Anle138b，98% | C16H11BrN2O2 | |||
|
|
|||||
|
(2-Chloropyridin-4-yl)methanamine hydrochloride，98% | C6H8Cl2N2 | |||
|
|
|||||
|
FITM，98% | C18H18FN5OS | |||
|
|
|||||
|
Guanethidine Monosulfate，98% | C10H24N4O4S | |||
|
|
|||||
|
CCMI，98% | C19H15Cl2N3O2 | |||
|
|
|||||
|
Verubecestat，99% | C17H17F2N5O3S | |||
|
|
|||||
|
Edonerpic maleate，98% | C20H25NO6S | |||
|
|
|||||
|
Rivastigmine，98% | C18H28N2O8 | |||
|
|
|||||
|
Darifenacin HBr，99% | C28H30N2O2.HBr | |||
|
|
|||||
|
Lanabecestat，99% | C26H28N4O | |||
|
|
|||||
|
LY3039478，98% | C22H23F3N4O4 | |||
|
|
|||||
|
SQ 22,536，98% | C9H11N5O | |||
|
|
|||||
|
YO-01027，98% | C26H23F2N3O3 | |||
|
|
|||||
|
IMR-1，99% | C15H15NO5S2 | |||
|
|
|||||
|
FLI-06，99% | C25H30N2O5 | |||
|
|
|||||
|
VU 0357121，99% | C17H17F2NO2 | |||
|
|
|||||
|
VU 0364770，99% | C12H9ClN2O | |||
|
|
|||||
|
RO4929097，98% | C22H20F5N3O3 | |||
|
|
|||||
|
ADX-47273，98% | C20H17F2N3O2 | |||
|
|
|||||
|
Ipratropium bromide，98% | C20H30BrNO3 | |||
|
|
|||||
|
M1 receptor modulator，99% | C25H25N3O2 | |||
|
|
|||||
|
PNU-282987，99% | C14H17ClN2O | |||
|
|
|||||
|
Mc-Val-Cit-PABC-PNP，97% | C35H43N7O11 | |||
|
|
|||||
|
Imidafenacin，98% | C20H21N3O | |||
|
|
|||||
|
LY341495，98% | C20H19NO5 | |||
|
|
|||||
